Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 82.43
-0.18 (-0.22%)
Dec 29, 2025, 11:29 AM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 33.72 billion as of December 26, 2025. Its market cap has increased by 13.71% in one year.
Market Cap
33.72B
Enterprise Value
33.04B
Revenue
3.34B
Ranking
n/a
PE Ratio
35.76
Stock Price
82.43
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 33.72B, an increase of 134.82%. That is a compound annual growth rate of 15.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 33.72B | 12.98% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 407.46B |
| WuXi AppTec | 271.20B |
| Shenzhen Mindray Bio-Medical Electronics | 243.61B |
| Sichuan Biokin Pharmaceutical | 136.66B |
| Shanghai United Imaging Healthcare | 106.29B |
| Aier Eye Hospital Group | 103.55B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.71B |
| Yunnan Baiyao Group Co.,Ltd | 101.27B |